DIPG

11 registered clinical trials studyying DIPG — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Gli NCT07331064	Sarah Rumler	Phase 1
Recruiting	Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for NCT06607692	Fundación de investigación HM	Phase 1 / Phase 2
Recruiting	xPedite: A Study to Expedite DIPG and DMG Research NCT06140719	xCures	—
Withdrawn	131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma NCT05063357	Y-mAbs Therapeutics	Phase 1
Completed	INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas NCT04295759	Pediatric Brain Tumor Consortium	Phase 1
Completed	HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Care NCT04670016	University of Calgary	—
Recruiting	A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma NCT04250064	Tata Memorial Centre	Phase 2
Active Not Recruiting	Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and NCT03478462	Cellectar Biosciences, Inc.	Phase 1
Terminated	Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Gliom NCT02758366	Meyer Children's Hospital IRCCS	Phase 2
Unknown	Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma NCT01952769	Hadassah Medical Organization	Phase 1 / Phase 2
Completed	A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas NCT01837862	Julie Krystal	Phase 1 / Phase 2